Sort
15,842 grants matching “pancreatic cancer”
Biology and Immunology of Pancreatic Cancer Stem Cells in a Novel Mouse Model
$470,159Edgar G. Engleman · Stanford University · U01 · FY2011 · CA
Phase I/II clinical evaluation of ABTL0812, a novel PI3K/Akt/mTOR inhibitor, with a unique mechanism of action inpancreatic cancer (Protocol sent on 20th June 2019 as an amendment of the IND 137394)
$470,000Davendra Sohal · University Of Cincinnati · R01 · FY2020 · FD
Confocal imaging resources for the JHU Zebrafish Center
$469,986Steven D Leach · Johns Hopkins University · S10 · FY2010 · RR
TOR signaling and autophagy in obesity-promoted liver tumorigenesis
$469,980Michael Karin · University Of California, San Diego · R01 · FY2014 · CA
Pixel-accurate oncologic therapy using a scanning fiber endoscope
$469,897Eric J Seibel · University Of Washington · R01 · FY2010 · EB
NGF recruits nerve fibers to reprogram an immunosuppressive microenvironment in melanoma
$469,848Xiao-Fan Wang · Duke University · R01 · FY2021 · CA
Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy
$469,682Lily Yang · Emory University · U01 · FY2019 · CA
Consortium for the study of chronic pancreatitis, diabetes and pancreatic cancer: Pittsburgh Clinical Center
$469,495Dhiraj Yadav · University Of Pittsburgh At Pittsburgh · U01 · FY2020 · DK
Consortium for the study of chronic pancreatitis, diabetes and pancreatic cancer: Pittsburgh Clinical Center
$469,495Dhiraj Yadav · University Of Pittsburgh At Pittsburgh · U01 · FY2021 · DK
Targeting tumor architecture as a novel therapeutic strategy for pancreatic cancer
$469,327Matteo Ligorio · Ut Southwestern Medical Center · R37 · FY2025 · CA
Lysyl Oxidase Propeptide: Breast Cancer Inhibitor
$469,312Gail E Sonenshein · Tufts University Boston · R01 · FY2013 · CA
A Fragment-Based Strategy for K-RAS Covalent Inhibitors
$469,217Samy Meroueh · Indiana University Indianapolis · R01 · FY2021 · CA
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
$469,135Karen M Mann · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Gut pathogen virulence and its therapeutic modulation during surgical injury
$469,029John C. Alverdy · University Of Chicago · R01 · FY2023 · GM
Multifactor risk scores with susceptibility gene mutations to enhance risk assessment of pancreatic cancer
$468,867Ann Laura Oberg · Mayo Clinic Rochester · R01 · FY2023 · CA
The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer
$468,829Suresh T. Chari · University Of Tx Md Anderson Can Ctr · U01 · FY2020 · DK
GENOMICS OF APOPTOSIS &ANGIOGENESIS IN ISLET CARCINOMA
$468,795University Of California San Francisco · R01 · FY2000 · CA
Role of Neurogenic Inflammation in Pancreatic Cancer
$468,647Brian M Davis · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · CA
TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression
$468,594Joan Massague · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression
$468,594Joan Massague · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression
$468,594Joan Massague · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression
$468,594Joan Massague · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Universal Internal Standard for Reproducible Accurate Quantification of Exosome Protein Markers
$468,551David M. Lubman · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Whole Genome Scan in the Pancreatic Cancer Cohort Consortium (PanScan)
$468,522Rachael Stolzenberg-Solomon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
Prospective Study of Human Oral Microbiome and Pancreatic Cancer Risk
$468,512Jiyoung Ahn · New York University School Of Medicine · R01 · FY2017 · CA